Click to search for your profile
Click to search for condition or expert
Click to open main menu
Save Condition
Bookmark
Share
Share
Condition
Latest Advances in
Axial Spondyloarthritis
Overview
Find a Doctor
Latest Advances
Clinical Trials
Latest Advances
Condition:
Axial Spondyloarthritis
Journal:
PloS one
Treatment Used:
Tumor Necrosis Factor A Inhibitors (TNFi)
Number of Patients:
16
Published —
December 31, 2020
This study evaluated the impact of tumor necrosis factor a inhibitors (medicines that suppress the body's natural response to tumor necrosis factor, a protein produced by white blood cells that is involved in early inflammatory events; TNFi) in patients with axial spondyloarthritis (chronic, autoinflammatory disease predominantly affecting the axial skeleton, which is the central axis of the body and includes the bones of the skull, ossicles of the middle ear, hyoid bone of the throat, vertebral column, and the ribcage).
Condition:
Axial Spondyloarthritis
Journal:
RMD open
Treatment Used:
Secukinumab
Number of Patients:
1860
Published —
September 20, 2020
This study explored the effectiveness of 6-month and 12-month secukinumab in patients with axial spondyloarthritis (spinal degeneration; axSpA).
Condition:
Axial Spondyloarthritis
Journal:
Arthritis research & therapy
Treatment Used:
TNF Inhibitors
Number of Patients:
193
Published —
August 23, 2020
This study investigated if switching TNF inhibitors after a primary or secondary failure provides good clinical outcomes in patients with axial spondyloarthritis.
Condition:
Axial Spondyloarthritis
Journal:
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group
Treatment Used:
Serial Locally Applied Water-filtered Infrared a Radiation (sl-wIRAR)
Number of Patients:
71
Published —
August 13, 2020
In this study, researchers evaluated the outcomes of using serial locally applied water-filtered infrared A radiation (sl-wIRAR) for the treatment of axial spondyloarthritis.
Condition:
Axial Spondyloarthritis
Journal:
Annals of the rheumatic diseases
Treatment Used:
Secukinumab
Number of Patients:
390
Published —
June 26, 2020
This study tested the safety and efficacy of using secukinumab to treat patients with axial spondyloarthritis that have already been previously treated with TNF inhibitors.
Condition:
Axial Spondyloarthritis
Journal:
RMD open
Treatment Used:
Certolizumab Pegol
Number of Patients:
89
Published —
May 07, 2020
The study researched the impact of certolizumab pegol treatment on the incidence of anterior uveitis flares in patients with axial spondyloarthritis.
Condition:
Axial Spondyloarthritis
Journal:
Mediators of inflammation
Treatment Used:
Secukinumab
Number of Patients:
39
Published —
April 23, 2020
This study tested the safety and efficacy of using secukinumab to treat patients with axial spondyloarthritis.
Condition:
Axial Spondyloarthritis (AxSpA)
Journal:
Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan
Treatment Used:
Qushi Xiezhuo Formula (QSXZF)
Number of Patients:
62
Published —
March 19, 2020
This study investigated the effect of Qushi Xiezhuo formula (QSXZF) on axial spondyloarthritis (autoinflammatory disease affecting the joints of the spine, chest and pelvis; AxSpA) with a high incidence of monosodium serum urate (MSU) crystal deposition (gout).
Condition:
Radiographic Progression in Axial Spondyloarthritis
Journal:
Arthritis & rheumatology (Hoboken, N.J.)
Treatment Used:
Tumor Necrosis Factor Inhibitors (TNFi), Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Secukinumab
Number of Patients:
0
Published —
January 22, 2020
This review of the literature investigated the effect of therapies on radiographic progression in patients with axial spondyloarthritis (spinal arthritis; SpA).
Condition:
Axial Spondyloarthritis
Journal:
Journal of autoimmunity
Treatment Used:
Treat toTarget Strategy
Number of Patients:
0
Published —
January 14, 2020
This article discusses a treat to target strategy for axial spondyloarthritis.
Condition:
Non-Radiographic Axial Spondyloarthritis
Journal:
Lancet (London, England)
Treatment Used:
Ixekizumab
Number of Patients:
303
Published —
December 10, 2019
In this study, researchers evaluated the safety and effectiveness of ixekizumab for the treatment of non-radiographic axial spondyloarthritis.
Condition:
Axial Spondyloarthritis
Journal:
PloS one
Treatment Used:
Add-On Training Program
Number of Patients:
24
Published —
December 03, 2019
This study tested the safety and efficacy of including a training program that incorporates breathing exercises, cold exposure, and meditation to improve clinical parameters in patients with axial spondyloarthritis.
Showing 1-12 of 31
Next